TigerShark Trading
Categories
Home
Currency
Futures
Options
Stocks
Authors
Search
 

Web
TigerShark
Popular Authors
  1. Adrian Manz
  2. Dave Mecklenburg
  3. Dave Landry
  4. Art Collins
  5. John Mauldin
  6. Bill Bonner
  7. Price Headley
  8. Lawrence G. McMillan
  9. Deron Wagner
  10. Kathy Lien
  11. Harry Boxer
  12. Boris Schlossberg
  13. James Mound
  14. Julie Peterson-Manz
No popular authors found.
Website Info
About Us
Advertising Info
How to Use the Site
Privacy Policy
Submitting Articles
Terms & Conditions
Syndicate
Site Map
 5 Stocks from Top Traders Every Sunday
 
Article Options
Popular Articles
  1. A 10-Day Trading System
  2. Use the Right Technical Tools When You Trade
  3. Weekend Interview with Navy SEAL Richard Machowicz
  4. Trading Stock Setups with the Accelerating Momemtum Strategy
  5. The Dave Landry Stock Swing Trading Mini-Course
No popular articles found.
Biotech (XBI) Breakout
By Mike Paulenoff | Published  03/2/2010 | Stocks | Unrated
Biotech (XBI) Breakout

Yesterday’s powerful upside breakout in the SPDR S&P Biotech ETF (XBI) continues today as the biotech sector remains “bid” in expectation of more takeover action and pipeline news. Yesterday was OSI Pharmaceuticals (OSIP), today was Dendreon (DNDN), with many other names in the group acting well, such as CELG, CEPH, BIIB, HGSI. As for the technical work, the XBI has an optimal target in the vicinity of 63.00 in the upcoming days.

 

Mike Paulenoff is a 26-year veteran of the financial markets and author of MPTrader.com.